These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29929418)

  • 1. Chemical restraint of adults with intellectual disability and challenging behaviour in Queensland, Australia: Views of statutory decision makers.
    Edwards N; King J; Williams K; Hair S
    J Intellect Disabil; 2020 Jun; 24(2):194-211. PubMed ID: 29929418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.
    Sheehan R; Hassiotis A; Strydom A; Morant N
    BMJ Open; 2019 Nov; 9(11):e032861. PubMed ID: 31780594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework.
    Barratt M; Jorgensen M; Deb SS; Limbu B; Donley M; Buchholtz M; Smith V; Wilson N
    J Appl Res Intellect Disabil; 2023 May; 36(3):486-496. PubMed ID: 36655535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent for medication in persons with mental retardation and mental illness.
    O'Sullivan JL; Borcherding BG
    Health Matrix Clevel; 2002; 12(1):63-92. PubMed ID: 12013701
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour.
    Bij de Weg JC; Honingh AK; Teeuw M; Sterkenburg PS
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers.
    de Kuijper G; de Haan J; Deb S; Shankar R
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging behaviours: Views and preferences of people with intellectual disabilities.
    Wolkorte R; van Houwelingen I; Kroezen M
    J Appl Res Intellect Disabil; 2019 Nov; 32(6):1421-1427. PubMed ID: 31183971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT.
    Hassiotis A; Poppe M; Strydom A; Vickerstaff V; Hall I; Crabtree J; Omar R; King M; Hunter R; Bosco A; Biswas A; Ratti V; Blickwedel J; Cooper V; Howie W; Crawford M
    Health Technol Assess; 2018 Mar; 22(15):1-110. PubMed ID: 29596045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.